| アブストラクト | BACKGROUND: The characteristics of care home populations, with respect to fracture risk factors, have not been well-defined. AIM: To describe osteoporosis-related characteristics among care home residents, including fracture risk factors, fracture rates, post-fracture outcomes, and osteoporosis treatment duration. DESIGN & SETTING: A descriptive cohort study of care home residents aged >/=60 years (n = 8366) and a matched cohort of non-care home residents (n = 16 143) in England from 2012 to 2019. Clinical Practice Research Datalink (CPRD) linked to Hospital Episode Statistics (HES) and Office for National Statistics (ONS) death data were used. METHOD: The characteristics were assessed using descriptive statistics. Fracture risk factors and fracture rates were described in both the care home and matched population. In the care home population, Kaplan-Meier curves were plotted to assess osteoporosis treatment duration. RESULTS: At index, fracture risk factors were more common in care home residents versus the matched cohort, including body mass index (BMI) <18.5 (12.2% versus 5.1%), history of falls (48.9% versus 30.7%), prior fracture (26.5% versus 10.8%), and prior hip fracture (17.1% versus 5.8%). Fracture rate was 43.5 (95% confidence interval [CI] = 39.7 to 47.5) in care home residents and 28.0 (95% CI = 26.3 to 29.9) per 1000 person-years in the matched cohort. Overall, osteoporosis treatment was initiated in 3.6% (n = 225/6265) of care home residents and 45.9% remained on treatment at 12 months. Among care home residents who experienced fracture, 21.9% (n = 72/329) received an osteoporosis diagnosis; 21.2% (n = 63/297) initiated osteoporosis treatment post-hip fracture. CONCLUSION: Care home residents had more fracture risk factors and higher fracture rates than the matched cohort; however, osteoporosis diagnosis, treatment rates, and treatment duration were low. There is an opportunity to improve osteoporosis management in this vulnerable population. |
|---|
| ジャーナル名 | BJGP open |
|---|
| Pubmed追加日 | 2023/2/23 |
|---|
| 投稿者 | Gerasimaviciute, Vaiva; Mathur, Rohini; Mansfield, Kathryn Elizabeth; McDermott, Matthew Paul; Neasham, David Edward; O'Kelly, James Liam |
|---|
| 組織名 | Amgen Ltd, Uxbridge Business Park, Uxbridge, UK vgerasim@amgen.com.;Center for Primary Care, Wolfson Institute of Population Health, Queen Mary;University of London, London, UK.;London School of Hygiene and Tropical Medicine, London, UK.;Amgen Ltd, Uxbridge Business Park, Uxbridge, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/36805457/ |
|---|
